Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH) [Phase 1]

View source ↗

Summary

This Phase 1 study completed a safety assessment of potential interactions between intravenous methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH) in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methamphetamine (methamphetamine)
  • Osmotic-Release Methylphenidate (OROS-MPH) (methylphenidate)

Snippet

Sponsor: University of Cincinnati | Conditions: Methamphetamine Dependence, Methamphetamine Abuse | Phase 1 | Status: COMPLETED